Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)
Background: The incidence of benign prostatic hyperplasia peaks 80% in old age. Bothersome symptoms and progression to acute urinary retention and need for surgery are important concerns. Apha blockers and 5 alpha reductase inhibitors address these to variable extents. This article reviews the curre...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Surgical Society of Kenya
2010-07-01
|
Series: | The Annals of African Surgery |
Online Access: | https://www.annalsofafricansurgery.com/combination-drug-therapy-for-benign |